# A Study of Topical BX005-A in Subjects With Moderate to Severe Atopic Dermatitis

> **NCT05240300** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **BiomX, Inc.**

## Conditions studied

- Atopic Dermatitis

## Interventions

- **BIOLOGICAL:** BX005-A
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05240300
- **Lead sponsor:** BiomX, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-05
- **Primary completion:** 2023-06
- **Final completion:** 2023-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study did not start enrollment due to business reasons
- **Last updated:** 2025-08-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05240300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05240300, "A Study of Topical BX005-A in Subjects With Moderate to Severe Atopic Dermatitis". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT05240300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*